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Abstract 
Ganoderma applanatum is a widely distributed saprobic or parasitic mushroom, it was found at 
the bases of decaying logs in Hakozaki Higashi-ku Fukuoka-shi. Japan. The mushroom was 
extracted with 80% methanol, and LC-HRMS analysis was conducted to illustrate the bioactive 
ingredients. The cytotoxicity of the total metabolite extract was evaluated against human colon 
cancer cell line (Caco-2) which showed IC50 value of 160±4.08 µg/ml. G. applanatum 
methanolic extract caused different morphological alterations and increased glutathione level in 
the treated cells. Interestingly, G. applanatum increased Bax/Bcl-2 ratio significantly (P˂0.05) at 
concentrations of 80 and 160 µg/ml on Caco-2 undergoing apoptotic p53-independent pathway 
with lake expression of p53 protein and up-regulated Cas-3 mRNA. The in vivo study on solid 
Ehrlich tumor (SEC) revealed a decrease in the volume of the developed tumor mass after five 
days of G. applanatum (200µg/ml) treatment. The apoptotic p53-dependant pathway was 
confirmed by mRNA Bax/Bcl-2 increased ratio in addition to p53 and Cas-3 up-regulation. In 
conclusion, G. applanatum could exert apoptotic antitumor properties in Caco-2 by p53-
independent pathway and p53-dependant in SEC. The findings proved that G. applanatum can be 
a promising candidate as alternative or co-anticancer medications.  
Keywords: Ganoderma applanatum, mushroom, anticancer, apoptosis, Caco-2, solid Ehrlich 
tumor. 
  
Introduction 
Cancer is one of the major human diseases and causes considerable suffering and economic 
loss worldwide. Colorectal cancer (CRC), with more than 750,000 deaths worldwide per year, is 
the third leading cause of cancer-related death in the Western world [1]. Chemotherapy counts 
more than 100 anticancer drugs with different mechanism of action [2]. Alarmingly, the current 
synthetic anti-cancer treatments available in market are not target specific and due to the 
increasing rate of mortality associated with cancer and toxic side effects of cancer chemo- and 
radiotherapies, which highlights the urgent need for new effective and less-toxic therapeutic 
drugs, discovery of new anticancer agents derived from nature has begun especially botanicals 
and the screening of natural products  as a source of anticancer molecules especially those that 
have cytotoxic properties with minimal side effects [3]. Fourteen thousand kinds of mushrooms 
are recently known [4]. Many searches studied the use of mushroom extracts in cancer 
treatments to complement chemotherapy and radiation therapy by decreasing the side-effects of 
cancer, such as, anemia , nausea, bone marrow suppression, , inflammation, and lowered 
resistance [5]. 
Antitumor bioactive compounds from mushrooms are of a significant importance. Recently, the 
anti-cancer agents include polysaccharides, proteins, fats, ash, glycosides, alkaloids, volatile oils, 
tocopherols, phenolics, flavonoids, carotenoids, folates, ascorbic acid enzymes, and organic 
acids. The active components in mushrooms responsible for conferring anti-cancer potential are 
polysaccharides, alkaloids, triterpenoids, polyphenols, etc [5]. Findings suggest that some 
mushrooms in combination with commercial anti-cancer drugs work have a synergetic effect in 
treating drug-resistant cancers [6]. Mushrooms are a source of antioxidants, anticancer, prebiotic, 
immunomodulating, anti-inflammatory, cardiovascular, anti-microbial, and hypoglycemic [7].  
Ganoderma applanatum is a medicinal farming crop which grows within the dead and living 
trees. Studies proved this genus to have a potent antimicrobial, anti-fibrotic and anti-tumor 
properties [8]. Other effects are attributed to a wide variety of bioactive components, such as 
polysaccharides, triterpenes, sterols, lectins and other proteins [9-10]. This study was conducted 
to evaluate the antioxidative potential of the extract and the cytotoxicity of the bioactive 
compounds of this genus on colorectal cancer cell line, Caco-2 Human Colon Cancer, the 
inhibition of some anti-apoptosis proteins by affecting the regulation of the responsible genes 
were also investigated. LC-HRMS analysis was used to evaluate the bioactive compounds and to 
investigate the significance of these metabolites in the biological activity.  
Materials and methods 
Collection and identification of mushroom 
The mushroom was collected from the parks of Hakozaki Higashi-ku Fukuoka-shi. Japan. It was 
cut from the barks of dead trees and identified as Ganoderma applanatum by Mycological 
Society of Japan.  
Extraction of mushroom metabolites 
The mushroom was cut into small pieces and extracted with 80% methanol. The total extract was 
concentrated at 37°C by the use of a rotary evaporator.  
LC-HRMS analysis  
High resolution mass spectrometric data were obtained using a Thermo Instruments MS system 
(LTQ XL/LTQ Orbitrap Discovery) coupled to a Thermo Instruments HPLC system (Accela 
PDA detector, Accela PDA auto sampler, and Accela pump). The following conditions were 
applied: capillary voltage 45 V, capillary temperature 260°C, auxiliary gas flow rate 10-20 
arbitrary units, sheath gas flow rate 40-50 arbitrary units, spray voltage 4.5 kV, mass range 100-
2000 amu (maximum resolution 30000). For LC/MS, a Sunfire C18 analytical HPLC column (5 
µm, 4.6 mm × 150 mm) was used with a mobile phase of 0 to 100% MeOH over 30 minutes at a 
flow rate of 1 ml.min−1. The exact mass obtained for eluted peaks was used to deduce the possible 
molecular formulae for such mass, and these formulae were searched in Dictionary of Natural 
Products, CRC press, online version, for matching chemical structures. 
Analysis of data was performed using Xcalibur 3.0 and dereplication using dictionary of natural 
products database V. 23.1 on DVD. 
In vitro study 
Cell line maintenance and procedure 
Human colon cancer cell line (Caco-2) was purchased from VACSRA, Egypt. 5×105 cells were 
grown in 5 ml of complete growth medium (Lonza, Basel, Switzerland ), RPMI-1640 medium 
supplemented with 10% fetal bovine serum, 1% (100 U/ml penicillin and 100 µg/ml 
streptomycin) at 37°C and 5% CO2 in T25 tissue culture flasks. The medium was changed with 
new one every 48 hrs.  
Evaluation of Cytotoxicity using neutral red uptake assay  
When Caco-2 cells reached confluency, they were detached using 0.2% (w/v) trypsin and 
transferred to 96-cluster-well-culture plates at a concentration of 1 × 104 cells/well. Each well 
contained 100 µl of cell suspension and the plates were incubated for 24 hrs to obtain a 
monolayer culture at 37°C under 5% CO2. After the incubation period, the old media was 
removed and 100 µl of medium free extract, serial dilutions of G. applanatum or 5-Fluorouracil 
(1.5 µg/ml) as a standard treatment was added into 96-cluster-well-culture plates (8 wells/test 
material) and the Caco-2 cells were incubated at 37°C in a humidified 5% CO2 incubator for 24 
hrs. Next, Caco-2 cells were exposed to neutral red dye (4 mg/ml) for 3 hours in serum free 
medium after treatments incubation time. Cells were washed with PBS then distained using (50% 
EtOH and 5% glacial acetic acid in distilled water). The absorbance was measured at 540 nm 
using spectrophotometer (Hewlett Packard, USA) [11]. All determinations were performed in 
triplicates. Cell growth inhibitory rate was calculated in the following equation:  
Inhibition% = (1 − Sample group OD/Control group OD) × 100  
The maximal half inhibitory concentration (IC50) of G. applanatum extract on Caco-2 cells was 
assessed as equivalent value of inhibitory curve. 
For further investigations, Caco-2 cells were incubated with 3 µl/ml DMSO, 1.5 µg/ml of 5-
Fluorouracil, IC25 or IC50 of G. applanatum extract for 24 hrs. Untreated group was served as a 
vehicle and the treatments were applied in triplicates.  
Morphological Examination by phase contrast inverted microscopy 
Treated cells and controls were examined for morphological changes using Olympus BX41 
(Japan) with 400× magnification and then representative photos were digitally captured. 
Acridine orange/ethidium bromide (AO/EB) dual fluorescent staining 
To detect the evidence of apoptosis, necrosis and viability of cells, dual staining of cells by 
AO/EB was carried out. Five microliters of treated and control cultured cells were stained with 
3µl of AO/EB stain (100 µg/ml) and immediately examined using the fluorescent microscope 
(Olympus BX41, Japan). Five hundred cells were evaluated and then representative photos were 
digitally captured. Green colored cells with intact structure indicate viable cells, whereas cells 
with orange to red color were dead while apoptotic cells showed the blebbed cytoplasmic 
membrane and nuclear fragmentation.  
Immunocytochemical staining 
Cells were grown on coverslips and then they were incubated for 24 hrs with various treatments 
when reaching 70% confluency. Then, the treated and control cells were processed for 
immunocytochemical reaction using an avidin biotin complex immunoperoxidase technique.  p53 
nuclear protein in addition to Bcl-2 and Bax cytoplasmic markers for apoptosis were detected 
using an anti-human p53, Bcl-2 and Bax monoclonal antibodies (Glostrup, Hovedstaden, 
Denmark). Additionally, nuclear proliferating antigen (Ki-67) immune reaction was evaluated 
also as a marker of cell proliferation using an anti-human Ki-67 monoclonal antibody (Glostrup, 
Hovedstaden, Denmark). Cells were examined blindly and fields were chosen randomly. Five 
fields per slide were scored. The mean percentage of positive cells in all groups was used as 
immunocytochemical scoring system (positive cells/total number of counted cells) ×100. Cells 
were examined (400×) using light microscope (Olympus BX 41, Japan) and representative photos 
were digitally captured. 
In vivo study 
Ehrlich tumor 
The Ehrlich ascitic tumor, derived from a spontaneous murine mammary adenocarcinoma was 
maintained in ascitic form by passages in Swiss mice by weekly intraperitoneal transplantation of 
106 tumor cells. The ascitic fluid was collected by intraperitoneal puncture using a sterile insulin 
syringe. Ascitic tumor cell counts were done in a Neubauer hemocytometer. The cells were found 
to be more than 99% viable using trypan blue dye exclusion method [12]. A model of solid 
Ehrlich carcinoma (SEC) was used in this study, where 2.5×106 of the Ehrlich carcinoma cells 
(ECC) obtained from the Pharmacology and Experimental Oncology Unit of the National Cancer 
Institute, Cairo University, Egypt, were implanted subcutaneously into the right thigh of the hind 
limb of mice.  
Animals and experimental design 
Female Swiss albino mice, 8 to 12 weeks old, weighing 25.9±2.4 g were housed in plastic cages 
at room temperature (20 ± 2 °C) in a 12-hrs light/dark cycle and free access to food and water in 
animal house of National Organization for Drug Control and Research. 
Animals (6 mice/group) were divided into three groups (Untreated control, 5-Fluorouracil, 
injected intraperitoneally at 20 mg/kg body weight and G. applanatum extract administered orally 
at 200 mg/kg body weight). After four days of tumor inoculation, the different treatments were 
continued for five days. The experiments were conducted according to the National Research 
Council’s guidelines. 
Assessment of the tumor volume (TV) of SEC 
Tumor volume was measured after the 1st and 5th days of different treatments, using a Vernier 
caliper (Tricle, China). The volume of developed tumor mass was calculated by the following 
formula:  
TV (mm3) = 4pi (A/2)2 × (B/2)  
Where A is the minor tumor axis; B the major tumor axis and pi equals to 3.14 [12]. 
Histological changes in SEC tissues   
The tumor was fixed in 10% neutral buffered formalin for 24 hrs, dehydrated in ethyl alcohol, 
cleared in xylene, and mounted in molten paraplast. Sections of 4–5 µm were obtained from the 
prepared blocks and stained with hematoxylin-eosin. Sections were examined using (Olympus 
BX 41, Japan) microscope. 
Immuonohistochemical staining of SEC tissues  
Tissue samples were fixed in neutral buffered formalin (10%), embedded in paraffin, and 
sectioned into 4 µm sections. Immunocytochemical reactions were performed using the 
peroxidase/anti-peroxidase (PAP) method [13]. Samples were analyzed using Image J software 
and the score was divided into four groups based on the percentage of positively stained tumor 
cells as follows: 0 (negative expression, 0% - 15%); 1+ (weak expression, 16% - 30%); 2+ 
(moderate expression, 31% - 60%) and 3+ (strong expression, 61% - 100%). 
Oxidative stress markers  
Lipid peroxidation (LPO) in the Caco-2 cells as well as SEC tissue homogenate was determined 
as described by [14]. The level of nitric oxide (NO) in the homogenate was evaluated as 
previously reported by [15]. Whereas, the level of glutathione (GSH) was investigated according 
to the method of [16]. 
Quantitative real time PCR  
Total RNA was purified from the Caco-2 cells as well as SEC tissue using an RNeasy Plus 
Minikit (Qiagen, Valencia, CA). cDNA was prepared using the RevertAid™ H Minus Reverse 
Transcriptase (Fermentas, Thermo Fisher Scientific Inc., Canada). The cDNA samples were run 
in triplicate for real-time PCR analysis. Real-time PCR reactions were performed using Power 
SYBR® Green (Life Technologies, CA) on an Applied Biosystems 7500 system. Relative values 
of gene expression were normalized to GAPDH. Primer sequences and accession numbers of the 
genes are provided in Table (1). 
Statistical analysis 
All results were expressed as the mean ± standard deviation. Data for multiple variable 
comparisons were analyzed by one-way analysis of variance (ANOVA). For the comparison of 
significance between groups, Duncan's test was used as a post hoc test, and probability level of 
(P˂0.05) was considered significant. 
  
Results  
LC-HRMS analysis of G. applanatum extract 
LC-HRMS analysis of G. applanatum methanolic extract revealed the presence of 47 metabolites 
(Table 2). Tentative identification of the quasi-molecular ion peaks and their molecular formulae 
indicated 45 known metabolites and 2 potentially new compounds where no natural hits was 
found for such formulae at the Dictionary of Natural products database. The identified 
compounds represent different chemical classes of natural products such as terpenes and 
polyketides, which represented the majority of the identified compounds, alkaloids, xanthones, 
isocoumarins, dibenzofurans, and peptides. Although about 15 of the identified compounds don’t 
possess any reported biological activity, 11 of the identified metabolites reported to have strong 
anticancer effect, some with antibacterial, antifungal, antiviral, anti-inflammatory, and 
antioxidant effects.  
In vitro study results 
Assessment of cytotoxicity in Caco-2 cells 
The inhibitory effect of G. applanatum on Caco-2 cells after 24 hrs of incubation was assessed 
by neutral red uptake assay and the half maximal inhibitory concentration (IC50) value was 
160±4.08 µg/ml (Figure 1). The inverted phase contrast observation also revealed the presence of 
cellular shrinkage and irregular shape appearance with G. applanatum incubations (Figure 2). 
Assessment of viability and morphological changes by acridine orange/ethidium bromide 
(AO/EB) dual fluorescent staining in Caco-2 cells 
Basic morphological changes in apoptotic cells can be detected by AO/EB dual fluorescent 
staining. Furthermore, it allows for the distinction between normal cells, early and late apoptotic 
cells, and necrotic cells. Therefore, AO/EB staining is a new qualitative and quantitative method 
to examine apoptosis [17]. Morphological features of apoptosis such as cytoplasmic membrane 
blebbing, chromatin condensation, nuclear fragmentation, shrinkage of cells were evaluated by 
fluorescent microscopy. The results showed statistically significant (P˂0.05) dose dependant 
alterations in treated Caco-2 cells when compared with the control cells which exhibited normal 
intact morphology with bright green staining (Figure 2). 
Immunocytochemical assessment of p53, Bcl-2 and Ki-67 protein expression in Caco-2 cells 
The expression of cytoplasmic Bcl-2 (anti-apoptotic protein) and nuclear Ki-67 (proliferation 
protein marker) were detected immunocytochemistry (Figure 2). The count of positive stained 
cells of both markers revealed statistically significant (P˂0.05) dose dependant down-expression 
in Caco-2 cells after G. applanatum (80 and 160 µg/ml) incubations (Figure 3). On the contrary, 
p53 (tumor suppressor protein) immuno-staining revealed negative reactivity in both control and 
treated cells. 
Quantitative real time PCR (qPCR) for Bcl-2, Bax and Cas-3 expression in Caco-2 cells 
In order to quantify the expression of Bcl-2, Bax and Cas-3 as apoptosis-related genes, the 
number of mRNA copies was evaluated by qPCR and the results were calculated based on 
calibration curve for corresponding GAPDH values. G. applanatum (80 and 160 µg/ml) induced 
statistically significant (P˂0.05) dose dependant down-regulation of Bcl-2 gene (Figure 4), while 
dose dependent up-regulation of Bax and Cas-3, from four to more than fivefold changes 
respectively, were countered in Caco-2 cells after 24 hrs of incubation. Moreover, the Bax/Bcl-2 
ratio has the tendency to increase significantly when compared with control (Figure 4). 
Assessment of oxidative status in Caco-2 cells 
Incubation of G. applanatum extract with Caco-2 cells for 24 hrs revealed statistically non 
significant (P˂0.05) changes in lipid peroxidation and nitric oxide levels with respect to the 
control values. However, the level of glutathione showed statistically significant (P˂0.05) dose 
dependent elevation after G. applanatum incubation. In contrast, 5-FU caused significant 
decrease in GSH levels (Figure 5). 
In vivo study results 
Assessment of solid Ehrlich tumor volume 
The effect on tumor growth inhibition was evaluated as the volume of developed tumor mass on 
the 9th day after ECC cells implantation which showed significant (P˂0.05) tumor growth 
inhibition, as measured as volume change, after five days of G. applanatum (200 µg/ml) 
treatment when compared with the control ESC group (Figure 6).   
Assessment of oxidative status in solid Ehrlich tumor tissues 
Lipid peroxidation, nitric oxide and glutathione levels were estimated in SEC tissue. The 
obtained results illustrated that G. applanatum (200 µg/ml) caused statistically significant 
elevation (P˂0.05) in GSH levels with respect to the control values. However, G. applanatum 
treatment decreased the level of LPO (Figure 7).  
Histological changes in SEC tissues 
Concerning histological observations, the SEC showed more abundant necrotic lesions in G. 
applanatum treated group, with some occasional residual SEC cells, in addition to the 
appearance of shrunk cells around the necrotic areas. 5-Fluorouracil treated groups showed less 
alteration than that of the tested extract group, while the untreated group showed normal tumor 
architecture (Figure 8). 
Immunohistochemical assessment of p53, Bax and Bcl-2 expression in SEC tissues 
Tumor suppressor protein, p53, was elevated significantly (P˂0.05) in the treated groups with 
respect to the control values. Additionally, immunohistochemical localization of Bax protein 
showed significant elevation (P˂0.05) when compared with the control sections (Figure 9). On 
the other hand, Bcl-2 as an anti-apoptotic marker, exhibited less positive immune-reactivity with 
cytoplasmic brown stain development (Figure 8). Moreover, the apoptotic efficacy of the 
examined extract was also proved by calculating Bax/Bcl-2 ratio which has the tendency to 
increase significantly (P˂0.05), about threefold with respect to the control (Figure 9). 
Quantitative real time PCR for Bcl-2, Bax and Cas-3 expression in SEC tissues 
The expression of several apoptosis related genes, Bcl-2, Bax and Cas-3, were relatively 
quantified as mRNA levels to investigate the molecular mechanism of antitumor properties of G. 
applanatum on ESC tissues. However, Bax and Cas-3 up-regulation was significantly (P˂0.05) 
recorded while the Bcl-2 expression revealed down-regulation in G. applanatum (200 µg/ml) 
group when compared with control. Bax/Bcl-2 ratio tends to increase with nine fold higher than 
that of the control (Figure 10).   
 
  
Discussion 
The main objective of this work was to study the potential anticancer activity of G. applanatum 
in vitro against Caco-2 cancer cell line and in vivo against murine solid tumor induced in mice. 
Reports have described interesting anticancer properties of mushroom [18-19]. According to 
Akindele et al. [20] patients may turn to integrative therapies when the disease they are battling 
does not respond to synthetic medical therapies and/or to help reduce symptoms. From previous 
studies, some mushrooms such as maitake mushroom (Grifola frondosa) has been found to fight 
cancer via different routes [21].  
LC-HRMS analysis of G. applanatum extract revealed the presence of 47 metabolites 
representing different chemical classes of natural products mainly terpenoids and polyketides. 
About 11 of the identified metabolites reported to have strong anticancer effect through different 
mechanisms, some with anti-inflammatory and antioxidant effects which would support the 
overall cytotoxic effect of the extract. Additionally, about 15 of the identified compounds don’t 
possess any reported biological activity, and they could have a potential in the cytotoxic effect 
exhibited by this extract. This would require more in-depth study. Applanoxidic acids A-H are a 
group of triterpenes which reported to have strong antitumor and antioxidant effect.  It was 
reported that polysaccharides previously isolated from G. applanatum have strong cytotoxic 
effect [22]. However, the way of extract preparation either doesn’t allow for polysaccharide 
extraction or the presence of high molecular weight polysaccharides which were not detected by 
the range of accurate mass used in our LCMS analysis. This could allow us to propose the 
cytotoxic effect of G. applanatum extract in this study was due to other naturally occurring 
metabolites in the methanolic extract. Hence, G. applanatum may have a cancer preventive effect 
and we found that G. applanatum concentration-dependently inhibited cell viability and 
exhibited apoptosis in vivo and in vitro. In Caco-2 cells, mushroom inhibited cell viability with 
an IC50 of approximately 160 µg/ml after 24 hrs incubation. The results suggest that 
G. applanatum caused cytotoxicity in Caco-2 cells. 
Oxidative stress played a crucial role in tumor progress. G. applanatum in the current study was 
showed antioxidant effect as evidenced by a significant reduction in lipid peroxidation and the 
production of pro-inflammatory marker, NO. It was reported that the production of NO in tissues 
could contribute to the carcinogenesis process [23] because overproduction of NO could lead to 
enhanced replication of genes and oxidative damage to DNA. Whereas, cancerous cells demand 
high ROS concentrations in order to maintain their high proliferation rate [24]. In the current 
experiment, G. applanatum not only significantly restrained lipid peroxidation and NO 
production, but also effectively increased the antioxidant defense system and exerted cytotoxicity 
against caco-2 cancer cells and murine solid tumor induced in mice. The results obtained in the 
present work suggest that some compounds present in the tested mushroom can restrain the 
cascade of events that takes place in oxidative stress.  
In cancer study, imbalance between oxidant and antioxidant molecules in cancer cells is serious 
for expecting whether cancer progression can be suppressed. For this reason, this study 
investigated the effect of mushroom on antioxidant enzyme levels. The level of oxidative stress 
markers, such as lipid peroxidation and glutathione are important indicators for cellular 
responses to various oxidative stresses [25]. A moderate increase in ROS can promote cell 
proliferation and differentiation. The increase of ROS production may depend on diverse 
mechanisms, such as the activation of oncogenes, aberrant metabolism, mitochondrial 
dysfunction, and loss of functional p53 [26]. Lipid peroxidation prevention and robust 
antioxidant system may be a valuable approach for cancer prevention and treatment [27].  
In the present study, we investigated the mRNA expression of caspase3, Bax and Bcl-2 and we 
found that mushroom was able to up-regulated caspases-3 and Bax along with down-regulating 
Bcl-2 expression. The test results led us to investigate the modulation of p53 protein and cell 
cycle arrest of cancer cells after administration of the mushroom. Up-regulation of p53 protein 
associated with cell cycle arrest at sub-G1 stage clearly points out the actual cause of drug 
induced DNA damage [28]. The over-expression of apoptotic protein Bax, the lower-expression 
of antiapoptotic protein Bcl-2 clearly indicates that there were considerable changes in the 
balance of this protein ratio which triggered the beginning of the apoptotic process [28]. 
Bax/Bcl-2 ratio is a cell death switch in response to apoptotic stimuli. The elevation in Bax/Bcl-2 
ratio participates to the release of cytochrome C from mitochondria and activates the intrinsic 
mitochondrial apoptotic pathway. As a result, change in Bax and Bcl-2 expression determines 
cell susceptibility to apoptotic stimuli. An increased Bax/Bcl-2 ratio can activate caspase-3 and 
result in apoptosis [29]. Administration of G. applanatum to Caco-2 cells and murine mice with 
mushroom significantly increased the Bax and decreased the Bcl-2 mRNA and protein 
expressions. The altered ratio of pro-apoptotic and anti-apoptotic factors favored the promotion 
of apoptosis. Therefore, mushroom reduced the ability of Bcl-2 to bind to Bax and enhanced the 
translocation of Bax from cytosol to mitochondria, further increasing the susceptibility of the 
cells to apoptosis [28]. The obtained findings demonstrated the ability of mushroom to induce 
apoptosis. 
In the current study, G. applanatum showed potent anticancer effect in vivo and in vitro with 
different pathways. The compounds of mushroom extract may be metabolized by the mice 
leading to generation of different bioactive compounds or the metabolism may activate some 
compounds of mushroom that are inactive in the cell culture conditions. Furthermore, these 
metabolites may enhance expression of some silenced genes as resulted in p53 mRNA of mice 
solid tumor in the current study. All these suggestions could support the different level of tumor 
growth inhibitory effects. In conclusion, the more inhibitory effect of mushroom on tumor 
growth in vivo might be caused by some more effective metabolites of mushroom. Future 
research to explore the metabolism of mushroom extract is needed to clarify the impact of 
biotransformation on the efficacy of G. applanatum extracts in vivo. 
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Figure legends 
Figure 1. In vitro cytotoxicity activity of the G. applanatum extract on Human colon cancer cell 
line (Caco-2) after exposure to the extract for 24 hrs.  
Data represents means of three independent experiments; bars, standard deviation and a: 
significant with respect to the control (P˂0.05). 5-FU: 5-Fluorouracil (1.5 µg/ml). 
Figure 2. Representative photomicrographs of control and treated Caco-2 cells after 24 hrs. 
Morphological changes as observed by inverted microscope (phase contrast); viability, mode and 
stages of cell death as detected by acridine orange/ethidium bromide (AO/EB) dual fluorescent 
staining show the development of membrane blebbing (white arrows) and apoptotic nuclear 
fragmentation as hallmark of apoptotic mode of death, reddish necrotic nuclei and intact green 
viable cells; protein expression as evaluated by immunocytochemical reactivity, Bcl-2 (-ve cells, 
black arrows), Ki-67 (-ve cells, red arrows) and p53 (-ve with all treatments). 5-FU: 5-
Fluorouracil (1.5 µg/ml), G.a: G. applanatum. 
Figure 3. Effect of G. applanatum on the percentage of positively stained cells of Bcl-2 and Ki-
67 detected by immunocytochemistry in control and treated Caco-2 cells after 24 hrs.  
Data represents means of ten different fields; bars, standard deviation and a: significant with 
respect to the control (P˂0.05). 5-FU: 5-Fluorouracil (1.5 µg/ml). 
Figure 4. Effect of G. applanatum on the relative mRNA alterations of Bax, Cas-3 and Bcl-2 
expression, and Bax/Bcl-2 ratio in Caco-2 cells.  
Data represented the average of three replicates; bars, standard deviation and a: significant with 
respect to the control (P˂0.05). 5-FU: 5-Fluorouracil (1.5 µg/ml). 
Figure 5. Effect of G. applanatum on lipid peroxidation (LPO), nitric oxide (NO) and 
glutathione (GSH) levels in Caco-2 cells after 24 hrs.  
Data represents means of three independent experiments; bars, standard deviation and a: 
significant with respect to the control (P˂0.05). 5-FU: 5-Fluorouracil (1.5 µg/ml). 
Figure 6. Effect of G. applanatum on the solid Ehrlich tumor volume after five days of 
treatment.  
Data represents means (n= 5); bars, standard deviation and a: significant with respect to the 
control (P˂0.05). 5-FU: 5-Fluorouracil (20 mg/kg, i.p.). 
Figure 7. Effect of G. applanatum on lipid peroxidation (LPO), nitric oxide (NO) and 
glutathione (GSH) levels in solid Ehrlich tumor tissues after 4 days of treatment.  
Data represents means (n= 5); bars, standard deviation and a: significant with respect to the 
control (P˂0.05). 5-FU: 5-Fluorouracil (20 mg/kg, i.p.). 
Figure 8. Representative photomicrographs of control and treated solid Ehrlich tumor sections 
taken from the different treatment group and stained by H&E showing extensive necrotic areas 
(N); Bcl-2 and Bax protein expression as detected by immunohistochemistry show more positive 
reactivity with increased brown color development as cytoplasmic localization while p53 
expression as nuclear localization. 5-FU: 5-Fluorouracil (20 mg/kg, i.p.), G.a: G. applanatum. 
Figure 9. Effect of G. applanatum on the percentage of positively stained cells of Bcl-2, Bax and 
p53 as detected by immunocytochemistry in control and treated mice-bearing SEC tissues (left 
panel). Effect of G. applanatum on Bax/Bcl-2 ratio (right panel).  
Data represents means of ten different fields; bars, standard deviation and a: significant with 
respect to the control (P˂0.05). 5-FU: 5-Fluorouracil (20 mg/kg, i.p.). 
Figure 10. Effect of G. applanatum on the relative mRNA expression of Bax, Cas-3 and Bcl-2, 
and Bax/Bcl-2 ratio in ESC tissues isolated from mice-bearing solid Ehrlich tumor.  
Data (means of three assays) were normalized to the GAPDH mRNA level and expressed as fold 
induction relative to the mRNA level in the control. Bars, standard deviation and a: significant 
with respect to the control (P˂0.05). 5-FU: 5-Fluorouracil (20 mg/kg, i.p.). 
 
 
Table 1. Primer sequences of genes analyzed by real time PCR 
Name Accession number Sense (5'---3') Antisense (5'---3') 
GAPDH NM_017008.4 GCATCTTCTTGTGCAGTGCC GATGGTGATGGGTTTCCCGT 
Bcl-2 NM_016993.1 CTGGTGGACAACATCGCTCTG GGTCTGCTGACCTCACTTGTG 
Bax NM_017059.2 GGCGAATTGGCGATGAACTG ATGGTTCTGATCAGCTCGGG 
Caspase 3 NM_012922.2 GAGCTTGGAACGCGAAGAAA TAACCGGGTGCGGTAGAGTA 
Bcl-2 NM_016993.1 CTGGTGGACAACATCGCTCTG GGTCTGCTGACCTCACTTGTG 
Abbreviations; SOD2: Manganese-dependent superoxide dismutase (MnSOD); CAT: Catalase; GPx1: Glutathione peroxidase 1. 
 
Table 2. LC-HRESIMS analysis of G. applanatum extract. 
Accurate 
m/z 
Quasi-
form 
Suggested 
formulaa 
Tentative 
identificationb 
Structure Chemical 
class 
Activity 
294.20544 [M+H]+ C17H27NO3 Nobilonine 
 
Alkaloid No reported activity 
408.23779 [M+H]+ C22H33NO6 berkedrimane B 
 
Alkaloid Cytotoxic [30] 
223.18076 [M+H]+ C13H22N2O  Nigragillin 
 
Alkaloid  No reported activity  
334.12863 [M+H]+ C17H19NO6 8-
demethoxyhostasine 
O
N
O
O
HO
OH
OH
 
Alkaloid  Antiviral  
219.10173 [M+H]+ C13H14O3 7-Methoxy-2,3,6-
trimethylchromone 
 
Isocoumarin  Cytotoxic [31] 
237.11234 [M+H]+ C13H16O4 5-Hydroxy-6-ethyl-
7-methoxy-
methylchromanone 
 
Isocoumarin No reported activity 
279.15927 [M+H]+ C16H22O4 Cytosporone C 
 
Coumarin  Antimicrobial  
361.16507 [M+H]+ C20H24O6 4-Acetyl cis-
zearalenone 
 
Terpene  Mycotoxin  
417.22675 [M+H]+ C24H32O6 Presiccanochromenic 
acid 
 
Terpene  No reported activity 
345.16977 [M+H]+ C20H24O5 Myrocin C 
 
Terpene  Antimicrobial  
363.18030 [M+H]+ C20H26O6 Sphaeropsidin D 
 
Terpene  Cytotoxic [32] 
387.14383 [M+H]+ C21H22O7 Comazaphilone D 
 
Terpene  Antibacterial  
415.21146 [M+H]+ C24H30O6 Epoxy-4,4,14-
trimethyl-
3,7,11,15,20-
pentaoxo-pregnane 
 
Terpene  No reported activity 
449.25339 [M+H]+ C25H36O7 Erinacine H 
 
Terpene  Nerve growth factor 
stimulator 
527.26349 [M+H]+ C30H38O8 Applanoxidic acid C 
 
Terpene Antitumor [33] 
515.29987 [M+H]+ C30H42O7 Applanoxidic acid D 
 
Terpene Antitumor [34] 
513.28430 [M+H]+ C30H40O7 Applanoxidic acid E 
 
Terpene Antioxidant  
511.26877 [M+H]+ C30H38O7 Applanoxidic acid F 
 
Terpene  Antitumor [33]  
529.27917 [M+H]+ C30H40O8 Applanoxidic acid G 
O
O
O
O
OH
OH
O OH
 
Terpene Antitumor [33]  
531.29480 [M+H]+ C30H42O8 Applanoxidic acid H 
 
Terpene No reported activity 
549.30524 [M+H]+ C30H44O9 20-
Hydroxylganoderic 
acid G 
 
Terpene No reported activity 
357.13345 [M+H]+ C20H20O6  Deoxyherqueinone 
 
Terpene Antimicrobial  
493.35190 [M+H]+ C29H48O6 Xylariacin B 
 
Terpene  Cytotoxic [35] 
401.23218 [M+H]+ C24H32O5 Dendryphiellin E 
 
Terpene No reported activity 
485.32584 [M+H]+ C30H44O5 Camphoratin E   
 
Terpene anti-inflammatory, 
cytotoxic [36] 
475.34146 [M+H]+ C29H46O5 Trichiol C 
 
Terpene Cytotoxic [37] 
495.27344 [M+H]+ C30H38O6 Zeylasteral 
 
Terpene Antimicrobial  
545.27386 [M+H]+ C30H40O9 Citreohybridone E 
 
Terpene No reported activity 
499.30515 [M+H]+ C30H42O6 Sodagnitin A 
 
Terpene No reported activity 
497.28922 [M+H]+ C30H40O6 Bovistol 
 
Terpene  No reported activity 
361.16470 [M+H]+ C20H24O6 Chaetoquadrin A 
 
Polyketide  Antifungal  
435.23755 [M+H]+ C24H34O7 Verrucosidinol 
 
Polyketide  No reported activity 
267.12311 [M+H]+ C14H18O5 Papyracon A 
 
Polyketide  Antimicrobial 
433.22171 [M+H]+ C24H32O7 Heptemerone D 
 
Polyketide  Cytotoxic [38] 
447.23749 [M+H]+ C25H34O7 Atranone B 
 
Polyketide  phytotoxic 
461.18042 [M+H]+ C24H28O9 Daldinin F 
 
Polyketide  Antioxidant   
547.28943 [M+H]+ C30H42O9 Stemphone B 
O
O
O
O
O OOH
OH
HO
H
H
 
Polyketide  Anti-MRSA 
493.25800 [M+H]+ C30H36O6 Arugosin G 
 
Polyketide  No reported activity 
389.15979 [M+H]+ C21H24O7 Divaricatic acid 
O
O
O
OH
OH
OH
O
 
Polyketide Antimicrobial  
399.21658 [M+H]+ C24H30O5 Condidymic acid 
 
Polyketide No reported activity 
417.11819 [M+H]+ C21H20O9 7-O-Glucosyl-
daidzein 
 
Isoflavonoid  Different 
bioactivities  
473.28958 [M+H]+ C28H40O6 14-
Epicochlioquinone B 
 
Xanthone  Antibacterial  
509.25305 [M+H]+ C30H36O7 nujiangexanthone B 
 
Xanthone Cytotoxic [39] 
516.34253 [M+H]+ C29H45N3O5 Beauverolide E 
 
Peptide  No reported activity 
338.34201 [M+H]+ C22H43NO 6-cis-docosenamide 
 
Fatty amide  No reported activity 
451.23224 [M+H]+ C24H34O8 No hits  Terpene  
530.31036 [M+H]+ C30H43NO7 No hits  steroidal 
alkaloid 
 
a
 High Resolution Electrospray Ionization Mass Spectrometry (HRESIMS) using XCalibur 3.0 and allowing for M+H / M+Na adduct. 
b
 The suggested compound according to Dictionary of Natural Products (DNP 23.1, 2015 on DVD) and Reaxys online database. 
 
  
  
 
Figure 1. Assessement of cell viability and morphological changes by acridine 
orange/ethidium bromide (AO/EB) dual fluorescent staining.    
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Figure 2.  Morphological changes observed by inverted microscope (phase contrast); 
detected by acridine orange/ethidium bromide (AO/EB) dual fluorescent staining  
  
  
  
  
  
 
  
Figure 3.  Percentage of protein expression (positively stained cells) of Bcl-2 and Ki-
67 detected by immunocytochemistry in control and treated Caco-2 cells after 24 hrs. 
  
  
  
Figure 4. The relative mRNA alterations of Bax, Cas-3 and Bcl-2expression were 
quantified in control and treated Caco-2 cells using quantitative real-time PCR, 
 
 
 
 
   
Figure 5.  Lipid peroxidation (LPO), nitric oxide (NO) and glutathione (GSH) levels 
in control and treated Caco-2 cells after 24 hrs. 
 
  
  
Figure 6. Marked decrease in solid Ehrlich tumor volume after five days of different 
treatments. 
 
  
  
Figure 7.  Effect of G. applanatum (200 µg/ml) treatments on lipid peroxidation 
(LPO), nitric oxide (NO) and glutathione (GSH) levels in solid Ehrlich tumor tissues 
after 4 days of different treatments. 
 
 
 
Figure 8. Representative photomicrographs of control and treated solid Ehrlich tumor 
sheets. 
  
Figure 9.  Percentage of protein expression (positively stained cells) of Bcl-2, Bax 
and p53 as detected by immunocytochemistry in control and treated mice-bearing 
SEC tissues. 
 Figure 10.  The relative mRNA alterations of Bax, Cas-3 and Bcl-2 expressions.  
